{
    "ticker": "BNAIW",
    "name": "Bionano Genomics, Inc.",
    "description": "Bionano Genomics, Inc. is a genomic analysis company that focuses on providing innovative solutions for the research and clinical markets. Founded in 2003 and headquartered in San Diego, California, Bionano is dedicated to advancing genomics through its proprietary optical genome mapping (OGM) technology. This cutting-edge platform enables researchers and healthcare professionals to visualize and analyze genetic variations in a way that traditional methods cannot. The company\u2019s flagship product, the Saphyr system, allows for the rapid and accurate detection of structural variants in genomes, which is crucial for understanding complex diseases such as cancer. Bionano's technology is paving the way for improved diagnostics and personalized medicine, offering researchers tools that enhance their ability to discover genomic alterations. The company is committed to expanding the accessibility of genomic insights to researchers and clinicians, thus supporting advancements in therapeutic development. With a focus on innovation, Bionano continues to enhance its product offerings and contribute to the evolving field of genomics.",
    "industry": [
        "Biotechnology",
        "Genomics"
    ],
    "headquarters": "San Diego, California, USA",
    "founded": "2003",
    "website": "https://www.bionanogenomics.com",
    "ceo": "Erik Holmlin",
    "social_media": {
        "twitter": "https://twitter.com/bionanogenomics",
        "linkedin": "https://www.linkedin.com/company/bionano-genomics/",
        "youtube": "https://www.youtube.com/channel/UC1F5T8sW5S5zA9eU4XyFb7g"
    },
    "investor_relations": "https://investors.bionanogenomics.com",
    "key_executives": [
        {
            "name": "Erik Holmlin",
            "position": "CEO"
        },
        {
            "name": "Cynthia S. K. Liu",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Genomic Analysis",
            "products": [
                "Saphyr System",
                "NanoChannel Technology"
            ]
        }
    ],
    "seo": {
        "meta_title": "Bionano Genomics, Inc. | Advancing Genomic Analysis",
        "meta_description": "Explore Bionano Genomics, Inc., a leader in genomic analysis solutions with innovative optical genome mapping technology. Learn more about our products and impact on genomics.",
        "keywords": [
            "Bionano Genomics",
            "Genomic Analysis",
            "Optical Genome Mapping",
            "Saphyr System"
        ]
    },
    "faq": [
        {
            "question": "What is Bionano Genomics known for?",
            "answer": "Bionano Genomics is known for its innovative optical genome mapping technology that allows researchers to visualize genomic variations."
        },
        {
            "question": "Who is the CEO of Bionano Genomics?",
            "answer": "Erik Holmlin is the CEO of Bionano Genomics, Inc."
        },
        {
            "question": "Where is Bionano Genomics headquartered?",
            "answer": "Bionano Genomics is headquartered in San Diego, California, USA."
        },
        {
            "question": "What are Bionano Genomics' main products?",
            "answer": "Bionano Genomics' main products include the Saphyr System and NanoChannel Technology."
        },
        {
            "question": "When was Bionano Genomics founded?",
            "answer": "Bionano Genomics was founded in 2003."
        }
    ],
    "competitors": [
        "ILMN",
        "PACB",
        "GRMN"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "VRTX",
        "REGN"
    ]
}